Taylor Wealth Management Partners Biomarin Pharmaceutical Inc Transaction History

Taylor Wealth Management Partners

  • $176 Million
  • Q2 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 02, 2021
SELL
$72.61 - $90.2 $714,264 - $887,297
-9,837 Closed
0 $0
Q3 2020

Oct 14, 2020
SELL
$71.87 - $131.03 $1.11 Million - $2.03 Million
-15,476 Reduced 61.14%
9,837 $748,000
Q2 2020

Jul 27, 2020
BUY
$79.55 - $124.22 $2.01 Million - $3.14 Million
25,313 New
25,313 $3.12 Million

Others Institutions Holding BMRN

# of Institutions
623
Shares Held
181M
Call Options Held
1.73M
Put Options Held
1.73M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $15.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Taylor Wealth Management Partners Portfolio

Follow Taylor Wealth Management Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor Wealth Management Partners, based on Form 13F filings with the SEC.

News

Stay updated on Taylor Wealth Management Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email